{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:51:44Z","timestamp":1788519104910,"version":"build-2803163510"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T00:00:00Z","timestamp":1469059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kaken Pharmaceutical Co., Ltd."},{"name":"Kaken Pharmaceutical Co., Ltd."},{"name":"Kaken Pharmaceutical Co., Ltd."},{"name":"Kaken Pharmaceutical Co., Ltd."},{"name":"Kaken Pharmaceutical Co., Ltd."},{"name":"Kaken Pharmaceutical Co., Ltd."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0159661","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T14:01:13Z","timestamp":1469109673000},"page":"e0159661","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis"],"prefix":"10.1371","volume":"11","author":[{"given":"Yoshiki","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-8545","authenticated-orcid":false,"given":"Yoshiyuki","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"issue":"Suppl 2","key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-4362.1999.00015.x","article-title":"The scope of onychomycosis: epidemiology and clinical features","volume":"38","author":"E Haneke","year":"1999","journal-title":"Int J Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"MA Ghannoum","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1346-8138.2009.00741.x","article-title":"Epidemiological survey of foot diseases in Japan: Results of 30 000 foot checks by dermatologists","volume":"37","author":"S Watanabe","year":"2010","journal-title":"J Dermatol"},{"key":"ref4","first-page":"19","article-title":"Onychomycosis. Treatment, quality of life, and economic issues","volume":"1","author":"BE Elewski","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003495-199958020-00005","article-title":"Management of onychomycoses","volume":"58","author":"M Niewerth","year":"1999","journal-title":"Drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"S Murdan","year":"2002","journal-title":"Int J Pharm"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jps.20757","article-title":"Iontophoretic drug delivery across human nail","volume":"96","author":"Narasimha Murthy","year":"2007","journal-title":"J Pharm Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/IDR.S69596","article-title":"Efinaconazole in the treatment of onychomycosis","volume":"8","author":"SR Lipner","year":"2015","journal-title":"Infect Drug Resist"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1358\/dot.2015.51.10.2386986","article-title":"Tavaborole topical solution, 5% for the treatment of toenail onychomycosis","volume":"51","author":"LT Zane","year":"2015","journal-title":"Drugs Today"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/myc.12168","article-title":"Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis","volume":"57","author":"RK Scher","year":"2014","journal-title":"Mycoses"},{"key":"ref11","unstructured":"Iorizzo M, Arraiz G, Frisenda L, Caserini M, Mailland F. An innovative terbinafine transungual solution (P-3058): dose finding investigation on clinical benefit in patients affected by mild- to moderate toe onychomycosis. American Academy of Dermatology, 71st Annual Meeting, Miami Beach, Fla., Mar. 1\u20135, 2013."},{"key":"ref12","unstructured":"Faergemann J. An open, single-center pilot study of efficacy and safety of topical MOBO15B in the treatment of distal subungual onychomycosis (DSO). American Academy of Dermatology, 73rd Annual Meeting, San Francisco, CA, Mar. 20\u201324, 2015."},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/AAC.46.12.3797-3801.2002","article-title":"Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine","volume":"46","author":"Y Tatsumi","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","first-page":"609","article-title":"In vitro nail penetration and antifungal activity of tavaborole, a boron-based pharmaceutical","volume":"14","author":"D Coronado","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1128\/AAC.01739-15","article-title":"Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis","volume":"60","author":"Y Tabata","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","first-page":"778","article-title":"Fitzpatrick&apos;s Dermatology In General Medicine","author":"A Tosti","year":"2007"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1128\/AAC.00111-14","article-title":"Efinaconazole: low keratin affinity contributes to nail penetration and fungicidal activity in topical onychomycosis treatment","volume":"58","author":"K Sugiura","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.2042-7158.1997.tb06127.x","article-title":"In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: prediction of the penetration rate of antimycotics through the nail plate and their efficacy","volume":"49","author":"D Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"ref19","first-page":"1","article-title":"Progressive development in experimental models of transungual drug delivery of anti-fungal agents","author":"P Thatai","year":"2015","journal-title":"Int J Cosmet Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.11.009","article-title":"Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement","volume":"370","author":"MB Brown","year":"2009","journal-title":"Int J Pharm"},{"key":"ref21","unstructured":"Vontz CG, Nakamura N, Catherine De PM, Hughes J, Shah B, et al. Anti-fungal formulation. International patent WO 2010\/093992 A1, August 19, 2010."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.2042-7158.1997.tb06747.x","article-title":"In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: influence of the partition coefficient octanol\/water and the water solubility of drugs on their permeability and maximum flux","volume":"49","author":"D Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2014.11.017","article-title":"Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective","volume":"199","author":"MM Elsayed","year":"2015","journal-title":"J Control Release"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(91)90337-N","article-title":"Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate","volume":"76","author":"AF Davis","year":"1991","journal-title":"Int J Pharm"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(94)90395-6","article-title":"Effect of supersaturation on membrane transport: 2. Piroxicam","volume":"111","author":"MA Pellett","year":"1994","journal-title":"Int J Pharm"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/jps.22396","article-title":"An extended database of keratin binding","volume":"100","author":"S Hansen","year":"2011","journal-title":"J Pharm Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-4362.2001.01156.x","article-title":"Ciclopirox: an overview","volume":"40","author":"AK Gupta","year":"2001","journal-title":"Int J Dermatol"},{"key":"ref28","article-title":"CLSI document M38-A2","year":"2008"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/13693780802541518","article-title":"<italic>In vitro<\/italic> antifungal activities of luliconazole, a new topical imidazole","volume":"47","author":"H Koga","year":"2009","journal-title":"Med Mycol"},{"key":"ref30","unstructured":"Baker SJ, Hui X, Sanders V, Hold KM, Plattner JJ, Wester RC, et al. In vitro nail penetration of AN2690, effect of vehicle and coefficient of efficacy. American Academy of Dermatology, 65th Annual Meeting, Washington, DC, Feb. 2\u20136, 2007."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1468-3083.2011.04373.x","article-title":"Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs","volume":"27","author":"BE Elewski","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"AK Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2336\/nishinihonhifu.77.256","article-title":"Efficacy and safety of efinaconazole shown in Japanese patients with onychomycosis in the phase 3 global clinical trial","volume":"77","author":"S Watanabe","year":"2015","journal-title":"Nishinihon J Dermatol"},{"key":"ref34","unstructured":"Luconac<sup>\u00ae<\/sup> solution 5% (luliconazole) package insert. April 2016. Sato Pharmaceutical Co., Ltd. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/medinfo-sato.com\/products\/luconac\/document\/luconac_sato.pdf\" xlink:type=\"simple\">http:\/\/medinfo-sato.com\/products\/luconac\/document\/luconac_sato.pdf<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0159661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:24:28Z","timestamp":1540027468000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0159661"}},"subtitle":[],"editor":[{"given":"Joy","family":"Sturtevant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0159661","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]}}}